Evidence map›Paper›PMID 16672599›Full record

ArticleJournal of bacteriology2006

Ecf, an alternative sigma factor from Neisseria gonorrhoeae, controls expression of msrAB, which encodes methionine sulfoxide reductase.

Ishara C Gunesekere, Charlene M Kahler, Catherine S Ryan, Lori A S Snyder, Nigel J Saunders, Julian I Rood, John K Davies

Open access · greenAbstract read
In one paragraph

Article in Journal of bacteriology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. TheFrontiers in immunology · 2019
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Ishara C GunesekereAustralian Bacterial Pathogenesis Program, Department of Microbiology, Monash University, Clayton, VIC, Australia.
Charlene M Kahler
Catherine S Ryan
Lori A S Snyder
Nigel J Saunders
Julian I Rood
John K Davies
Monash University · AUUniversity of Oxford · GB

Funding

MICROBIAL PATHOGEN GENOME PROJECT--NEISSERIA GONORRHOEAER01AI038399 · NIAID · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI DYER, DAVID W. · 1995 to 1998
–
NIAID NIH HHS AI-38399Wellcome Trust
6 · The paper itself

Abstract

A DNA microarray was used to identify genes transcribed in Neisseria gonorrhoeae using Ecf, an alternative sigma factor. No differences between the transcriptional profiles of strain FA1090 and a mutant where ecf had been inactivated could be detected when both were grown in vitro. We therefore constructed a gonococcal strain in which Ecf can be overexpressed. Some differentially expressed genes are clustered with ecf on the genome and appear to form a single transcriptional unit. Expression of the gene encoding MsrAB, which possesses methionine sulfoxide reductase activity, was also dependent on Ecf, suggesting that the regulon responds to oxidative damage. Western blotting confirmed that the increased level of MsrAB protein is dependent on the presence of Ecf.

Indexed as

Gene Expression Regulation, BacterialBase SequenceDNA, BacterialDNA, ComplementaryDNA PrimersMethionine Sulfoxide ReductasesMolecular Sequence DataNeisseria gonorrhoeaeOxidoreductasesPlasmidsSigma FactorTranscription, GeneticDNA, BacterialDNA, ComplementaryDNA Primersmethionine sulfoxide reductaseMethionine Sulfoxide ReductasesOxidoreductasesSigma Factor

Identifiers

PMID16672599
PMCPMC1482861
OpenAlexW2118193588

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.